Literature DB >> 6282497

Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog.

S F Vatner, T H Hintze, P Macho.   

Abstract

We examined, in conscious dogs, the effects of beta-adrenergic stimulation on measurements of left circumflex coronary arterial diameter and blood flow and on calculations of late diastolic coronary resistance (LDCR) and left circumflex coronary internal cross-sectional area (CSA). Isoproterenol (0.1 microgram/kg) initially decreased mean arterial pressure by 25 +/- 2% (mean +/- SEM), and LDCR by 62 +/- 4%, and increased heart rate by 82 +/- 10%, left ventricular (LV) dP/dt by 79 +/- 12%, and mean coronary blood flow by 85 +/- 5%, while CSA rose slightly. The peak effects on CSA (24 +/- 2%) occurred later, along with decreases in mean arterial pressure (7.4 +/- 1.0%) and LDCR (25 +/-5.3%) and increases in coronary blood flow (14 +/- 2%), LV dP/dt (12 +/- 3%), and heart rate (24 +/- 4%). Pirbuterol (1.0 microgram/kg) induced changes that were qualitatively similar to those induced by isoproterenol. Prenalterol (20 micrograms/kg), a cardioselective beta 1-adrenergic receptor agonist, did not affect mean arterial pressure, but increased heart rate by 40 +/- 5%, LV dP/dt by 72 +/- 10%, mean coronary blood flow by 34 +/- 11%, and CSA by 26 +/- 3%, and decreased LDCR by 29 +/- 5+. Isoproterenol and pirbuterol, but not prenalterol, increased coronary sinus O2 content and decreased A-VO2 difference. After beta 1-adrenergic receptor blockade with atenolol (1 mg/kg), prenalterol no longer induced significant effects, whereas isoproterenol and pirbuterol decreased mean arterial pressure similarly to what was observed prior to blockade, but did not increase LV dP/dt, and induced attenuated increases in mean coronary blood flow, CSA, and decreases in LDCR. Thus, in the intact, conscious animal, large coronary arteries are regulated by beta-adrenergic mechanisms. Surprisingly, a major fraction of large coronary arterial dilation appeared to be either directly or indirectly due to beta 1-adrenergic receptor mechanisms, although beta 2-adrenergic effects were also significant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282497     DOI: 10.1161/01.res.51.1.56

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

Review 2.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.

Authors:  Q Liu; I Nakae; M Takahashi; A Takaoka; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

4.  The classification of beta-adrenoceptors in isolated ring preparations of canine coronary arteries.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

5.  Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogs.

Authors:  Gong Zhao; Suhua Zhang; John C Shryock; Xiaobin Xu; Manuel Ochoa; Thomas H Hintze; Luiz Belardinelli
Journal:  J Nucl Cardiol       Date:  2011-12-02       Impact factor: 5.952

6.  Differences in autonomic nerve function in patients with silent and symptomatic myocardial ischaemia.

Authors:  C F Shakespeare; D Katritsis; A Crowther; I C Cooper; J D Coltart; M W Webb-Peploe
Journal:  Br Heart J       Date:  1994-01

Review 7.  Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

Review 8.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

9.  Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs.

Authors:  Haoyi Yang; Youbin Deng; Xiaojun Bi; Qing Chang; Jiao Bai; Min Pan; Huijuan Xiang; Hongyun Liu; Xiulan Li; Yani Liu; Chunlei Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

10.  Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise.

Authors:  J B Gordon; P Ganz; E G Nabel; R D Fish; J Zebede; G H Mudge; R W Alexander; A P Selwyn
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.